4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000031
Chief Scientific Officer sold 3,961 shares at $18.00 ($71,316)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan Chief Scientific Officer | 2023-04-17 | Sale 10b5-1 | −3,961 | $18.00 | $71,316 | 171,325 | D |
| Open-market sales · 3,961 sh · avg $18.00 · $71,316 | |||||||
Loading xslF345X04/wf-form4_168194195395803.xml…